Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 04, 2020 07:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

WALTHAM, Mass., March 04, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today reported unaudited consolidated financial results for the fourth quarter and full year ended...
March 04, 2020 06:58 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces Changes to Medical Development Organization

WALTHAM, Mass., March 04, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced changes to its medical development organization. Effective March 31, 2020, Julie Krop,...
February 28, 2020 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Host Fourth Quarter and Full Year 2019 Financial Results Conference Call and Webcast on Wednesday, March 4, 2020 at 8:00 a.m. ET

WALTHAM, Mass., Feb. 28, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its fourth quarter and full year 2019 financial results will be released on...
February 14, 2020 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Participate in Upcoming Investor Conferences

WALTHAM, Mass., Feb. 14, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that management will participate in the following investor conferences: SVB Leerink 9th...
January 09, 2020 07:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces Leadership Transition, Results of Strategic Review to Unlock Shareholder Value and Financial Update

Initiating CEO transition plan Divesting Intrarosa® and Vyleesi® 2020 financial guidance reflects reduction in annual operating expenses of more than $100M and a return to positive adjusted EBITDA ...
January 03, 2020 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Jan. 03, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that management will present at the 38th Annual J.P. Morgan Healthcare Conference on...
December 18, 2019 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Awards Four Grants to Support Preterm Birth and Preeclampsia Research

WALTHAM, Mass., Dec. 18, 2019 (GLOBE NEWSWIRE) -- As part of the company’s ongoing support of research to reduce preterm birth and preeclampsia and associated complications, AMAG Pharmaceuticals,...
November 13, 2019 08:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals to Present at Upcoming Investor Conferences

WALTHAM, Mass., Nov. 13, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that company management will participate in the following investor conferences: Jefferies...
November 01, 2019 07:00 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Announces Third Quarter 2019 Financial Results and Provides Corporate Update

Commercial products achieve strong revenue and market share performance Vyleesi™ (bremelanotide injection) launched nationally in September Committed to work with the FDA to keep Makena available...
October 29, 2019 21:39 ET | Source: AMAG Pharmaceuticals, Inc.

AMAG Reports on FDA Advisory Committee Meeting for Makena® (Hydroxyprogesterone Caproate Injection)

WALTHAM, Mass., Oct. 29, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the U.S. Food and Drug Administration’s (FDA) Bone, Reproductive and Urologic Drugs...